Search research articles
Contact Us
Filters
Showing results (21-30 of 86) with videos related to
Page
of 9
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics
|
October 7, 2021
Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing
Sophia Liva, Min Chen, Amir Mortazavi, et al.
Investigational New Drugs
|
February 1, 2006
A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC)
Tanios S Bekaii-Saab, Amir Mortazavi, Lee G Hicks, et al.
Cancer Medicine
|
November 8, 2019
Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer
Ming Yin, Jing Zhao, Paul Monk, et al.
American Journal of Clinical Oncology
|
February 3, 2005
Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study?
Amir Mortazavi, Aasma Shaukat, Edress Othman, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
March 7, 2025
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
November 21, 2017
Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?
Huyen T Nguyen, Amir Mortazavi, Kamal S Pohar, et al.
Cells
|
January 11, 2024
Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma
Lingbin Meng, Katharine A Collier, Peng Wang, et al.
European Radiology
|
August 25, 2016
Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study
Huyen T Nguyen, Zarine K Shah, Amir Mortazavi, et al.
Analytical and Bioanalytical Chemistry
|
August 6, 2011
Potential analytical applications of lysenin channels for detection of multivalent ions
Daniel Fologea, Redwan Al Faori, Eric Krueger, et al.
Cancers
|
January 23, 2024
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines
Dixita M Patel, Ruba Mateen, Noor Qaddour, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 86) with videos related to
Sort By:
Page
of 9
European Journal of Drug Metabolism and Pharmacokinetics
|
October 7, 2021
Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing
Sophia Liva, Min Chen, Amir Mortazavi, et al.
Investigational New Drugs
|
February 1, 2006
A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC)
Tanios S Bekaii-Saab, Amir Mortazavi, Lee G Hicks, et al.
Cancer Medicine
|
November 8, 2019
Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer
Ming Yin, Jing Zhao, Paul Monk, et al.
American Journal of Clinical Oncology
|
February 3, 2005
Postoperative computed tomography scan surveillance for patients with stage II and III colorectal cancer: worthy of further study?
Amir Mortazavi, Aasma Shaukat, Edress Othman, et al.
Cancer Drug Resistance (Alhambra, Calif.)
|
March 7, 2025
Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches
Adam Khorasanchi, Feng Hong, Yuanquan Yang, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
November 21, 2017
Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?
Huyen T Nguyen, Amir Mortazavi, Kamal S Pohar, et al.
Cells
|
January 11, 2024
Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma
Lingbin Meng, Katharine A Collier, Peng Wang, et al.
European Radiology
|
August 25, 2016
Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study
Huyen T Nguyen, Zarine K Shah, Amir Mortazavi, et al.
Analytical and Bioanalytical Chemistry
|
August 6, 2011
Potential analytical applications of lysenin channels for detection of multivalent ions
Daniel Fologea, Redwan Al Faori, Eric Krueger, et al.
Cancers
|
January 23, 2024
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines
Dixita M Patel, Ruba Mateen, Noor Qaddour, et al.
Page
of 9